TY - JOUR
T1 - Impact of Sarcopenia and Obesity on Gait Speed After Total Knee Replacement
AU - Liao, Chun De
AU - Chen, Hung Chou
AU - Liou, Tsan Hon
AU - Lin, Che Li
AU - Huang, Shih Wei
N1 - Funding Information:
This work was supported by grants from Taipei Medical University?Shuang Ho Hospital, Ministry of Health and Welfare, Taipei, Taiwan (Grant 110TMU-SHH-04). The funding sources played no role in the design, implementation, data analysis, interpretation, or reporting of the study. The content of this publication is solely the responsibility of the authors. The authors declare no conflicts of interest.
Funding Information:
This work was supported by grants from Taipei Medical University–Shuang Ho Hospital , Ministry of Health and Welfare , Taipei, Taiwan (Grant 110TMU-SHH-04 ). The funding sources played no role in the design, implementation, data analysis, interpretation, or reporting of the study. The content of this publication is solely the responsibility of the authors. The authors declare no conflicts of interest.
Publisher Copyright:
© 2022 AMDA – The Society for Post-Acute and Long-Term Care Medicine
PY - 2022
Y1 - 2022
N2 - Objectives: Older adults with sarcopenic obesity have a higher risk of experiencing mobility difficulty. Additionally, sarcopenia and obesity are closely associated with knee osteoarthritis. This study investigated the associations of sarcopenia, obesity, and in combination of both with walking disability during postoperative rehabilitation in older adults with knee osteoarthritis who underwent total knee replacement. Design: A retrospective cohort study. Setting and Participants: From a rehabilitation center database, we retrospectively selected and investigated 482 older patients with knee osteoarthritis who had undergone total knee replacement and received postoperative rehabilitation. Methods: Sarcopenia was identified in accordance with the diagnostic criteria established by the Asian Working Group for Sarcopenia and obesity was defined as body mass index ≥ 30 kg/m2. Accordingly, patients were classified into four body composition groups, namely sarcopenic obese, sarcopenic, obese, and normal (reference group). After total knee replacement, all patients attended monthly follow-up admission during the postoperative rehabilitation. Gait speed was measured before surgery and monthly after total knee replacement. A gait speed cutoff of 1.0 m/s was used to identify postoperative walking disability. Kaplan–Meier curve analysis was performed to measure the probability of experiencing postoperative walking disability among the groups. Cox multivariate regression models were established to calculate the hazard ratios of postoperative walking disability. Results: Compared with the reference group, the sarcopenic, obese, and sarcopenic obese groups appeared to have a higher probability of experiencing postoperative walking disability (all P < .001). The sarcopenic obese group were likely to have the highest risk of experiencing postoperative walking disability (adjusted hazard ratio = 3.89). Conclusions and Implications: Sarcopenia or obesity alone may independently exert negative effects on postoperative gait speed. The participants with sarcopenic obesity were likely to have the highest risk of experiencing walking disability following total knee replacement. The findings may serve as a reference for clinicians developing rehabilitation strategies to optimize walking ability after total knee replacement, especially those preoperatively diagnosed as having sarcopenic obesity.
AB - Objectives: Older adults with sarcopenic obesity have a higher risk of experiencing mobility difficulty. Additionally, sarcopenia and obesity are closely associated with knee osteoarthritis. This study investigated the associations of sarcopenia, obesity, and in combination of both with walking disability during postoperative rehabilitation in older adults with knee osteoarthritis who underwent total knee replacement. Design: A retrospective cohort study. Setting and Participants: From a rehabilitation center database, we retrospectively selected and investigated 482 older patients with knee osteoarthritis who had undergone total knee replacement and received postoperative rehabilitation. Methods: Sarcopenia was identified in accordance with the diagnostic criteria established by the Asian Working Group for Sarcopenia and obesity was defined as body mass index ≥ 30 kg/m2. Accordingly, patients were classified into four body composition groups, namely sarcopenic obese, sarcopenic, obese, and normal (reference group). After total knee replacement, all patients attended monthly follow-up admission during the postoperative rehabilitation. Gait speed was measured before surgery and monthly after total knee replacement. A gait speed cutoff of 1.0 m/s was used to identify postoperative walking disability. Kaplan–Meier curve analysis was performed to measure the probability of experiencing postoperative walking disability among the groups. Cox multivariate regression models were established to calculate the hazard ratios of postoperative walking disability. Results: Compared with the reference group, the sarcopenic, obese, and sarcopenic obese groups appeared to have a higher probability of experiencing postoperative walking disability (all P < .001). The sarcopenic obese group were likely to have the highest risk of experiencing postoperative walking disability (adjusted hazard ratio = 3.89). Conclusions and Implications: Sarcopenia or obesity alone may independently exert negative effects on postoperative gait speed. The participants with sarcopenic obesity were likely to have the highest risk of experiencing walking disability following total knee replacement. The findings may serve as a reference for clinicians developing rehabilitation strategies to optimize walking ability after total knee replacement, especially those preoperatively diagnosed as having sarcopenic obesity.
KW - mobility
KW - obesity
KW - osteoarthritis
KW - Sarcopenia
KW - total knee replacement
UR - http://www.scopus.com/inward/record.url?scp=85125466046&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85125466046&partnerID=8YFLogxK
U2 - 10.1016/j.jamda.2022.01.056
DO - 10.1016/j.jamda.2022.01.056
M3 - Article
C2 - 35189122
AN - SCOPUS:85125466046
SN - 1525-8610
VL - 23
SP - 631
EP - 637
JO - Journal of the American Medical Directors Association
JF - Journal of the American Medical Directors Association
IS - 4
ER -